Brief: Biovica Receives FDA Approval For DiviTumTKa

Biovica International AB

01/08/2022 07:07

Aug 1 (Reuters) - Biovica International AB  BIOVICb.ST :
    * SAID ON SATURDAY FDA HAS GRANTED 510(K) CLEARANCE FOR THE
PRODUCT DIVITUMTKA

      
 Source text for Eikon:  ID:nMFN5pWvYM 
 Further company coverage:  BIOVICb.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))